|
|
0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
| Navn | Hopen Invest AS |
|---|---|
| Orgnr/født år | 992910925 |
| Ant aksjer | 101,212 |
| Omsetning | 0 |
| Driftsresultat | -3,545 |
| Egenkapital | 199,749 |
| Ant.eiere | 2 |
| Navn | Orgnr/født år | Aksjeklasse | Ant aksjer | Andel |
|---|---|---|---|---|
| Arvid Andreas Nergård | 1997 | Ordinære aksjer | 96,500 | 95.3% |
| Hopen Invest AS | 992910925 | Ordinære aksjer | 4,712 | 4.7% |
| Navn | Via | Ant aksjer | Andel | Egenkapital |
|---|---|---|---|---|
| Arvid Andreas Nergård | Hopen Invest AS | 4,493 | 4.4% | 0 |
| Hopen Invest AS | Hopen Invest AS | 219 | 0.2% | 0 |
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Arvto AS | 50 | 50.0% | 54 | 41 | -42 | 2 |
| Bergsfjorden Eiendom AS | 25 | 25.0% | 0 | -1 | 20 | 3 |
| Spirited Animals Group AS | 1,915 | 6.0% | 143 | 12 | 60 | 3 |
| Hopen Invest AS | 4,712 | 4.7% | 0 | -165 | 9,299 | 2 |
| Eli AS | 2,737 | 1.7% | -2 | 49 | 5 | |
| Lytix Biopharma AS | 481,117 | 1.2% | 48 | -1,162 | 616 | 1,097 |
| Pharma Holdings AS | 10,010 | 1.0% | 17 | -149 | 162 | 291 |
| Pharmasum Therapeutics AS | 14,126 | 0.4% | 6 | -6 | 12 | 683 |
| Amicoat AS | 99,966 | 0.3% | 58 | -15 | 184 | 311 |
* Justert for eierandel
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Spirited Animals Liquids AS | 1,800 | 5.7% | 6 | 1 | 2 | 2 |
| Es Licensed Operator Norway AS | 1,764 | 5.3% | -1 | -0 | 3 | |
| Arvto AS
Via Hopen Invest AS |
2 | 2.3% | 2 | 2 | -2 | 2 |
| Bergsfjorden Eiendom AS
Via Hopen Invest AS |
1 | 1.2% | 0 | -0 | 1 | 3 |
| Peptide Patents AS | 0 | 0.5% | 5 | -0 | 3 | 2 |
| Spirited Animals Group AS
Via Hopen Invest AS |
89 | 0.3% | 7 | 1 | 3 | 3 |
| Hopen Invest AS
Via Hopen Invest AS |
219 | 0.2% | 0 | -8 | 433 | 2 |
| Peptide Patents AS
Via Amicoat AS |
0 | 0.2% | 2 | -0 | 1 | 2 |
| Observe Medical ASA
Via Eli AS |
191,381 | 0.1% | 3 | -19 | 357 | 2,124 |
| Eli AS
Via Hopen Invest AS |
127 | 0.1% | -0 | 2 | 5 | |
| Lytix Biopharma AS
Via Hopen Invest AS |
22,399 | 0.1% | 2 | -54 | 29 | 1,097 |
| Pharma Holdings AS
Via Hopen Invest AS |
466 | 0.0% | 1 | -7 | 8 | 291 |
| Pharmasum Therapeutics AS | 674 | 0.0% | 0 | -0 | 1 | 683 |
| Pharmasum Therapeutics AS
Via Hopen Invest AS |
658 | 0.0% | 0 | -0 | 1 | 683 |
| Amicoat AS
Via Hopen Invest AS |
4,654 | 0.0% | 3 | -1 | 9 | 311 |
* Justert for eierandel
